Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1
- PMID: 3264072
- PMCID: PMC282716
- DOI: 10.1073/pnas.85.23.9248
Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1
Abstract
Human immunodeficiency virus type 1 (HIV-1), the retrovirus responsible for acquired immunodeficiency syndrome (AIDS), contains two heavily glycosylated envelope proteins, gp120 and gp41, which mediate attachment of virions to glycosylated cell surface receptor molecules (CD4 antigens) and appear to be responsible for syncytium formation and associated cytopathic effects of this virus. A comprehensive study of the effects of N-linked glycoprotein processing inhibitors on HIV-1 replication, infectivity, cytopathicity, target-cell infectibility, syncytium formation, and gp120 electrophoretic mobility was conducted to assess the importance of protein glycosylation in the pathogenesis of HIV-1 in vitro. The electrophoretic mobility of gp120 was decreased when gp120 was synthesized in the presence of castanospermine or 1-deoxynojirimycin (inhibitors of glucosidase I), increased when gp120 was synthesized in the presence of 1-deoxymannojirimycin (mannosidase I) or swainsonine (mannosidase II), and unaffected when gp120 was synthesized in the presence of bromoconduritol (glucosidase II). Inhibition by tunicamycin (lipid-linked oligosaccharide precursor synthesis), castanospermine, 1-deoxynojirimycin, and 1-deoxymannojirimycin attenuated HIV-1 infectivity and blocked HIV-1-induced syncytium formation and cytopathicity, whereas bromoconduritol and swainsonine failed to have such effects. None of the inhibitors interfered with virus replication in acutely infected cells or affected the ability of target cells to form syncytia with untreated HIV-1-infected cells. These results demonstrate that protein N-glycosylation is critical to the pathogenesis of HIV-1 at the levels of viral infectivity and cytopathicity but not at the level of virus replication or of host-cell infectibility.
Similar articles
-
Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1989 May;86(9):3384-8. doi: 10.1073/pnas.86.9.3384. Proc Natl Acad Sci U S A. 1989. PMID: 2541446 Free PMC article.
-
Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesis.AIDS Res Hum Retroviruses. 1987 Fall;3(3):265-82. doi: 10.1089/aid.1987.3.265. AIDS Res Hum Retroviruses. 1987. PMID: 2829950
-
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.Nature. 1987 Nov 5-11;330(6143):74-7. doi: 10.1038/330074a0. Nature. 1987. PMID: 2959866
-
[Structure and function of oligosaccharide chains of the envelope glycoprotein gp120 of human immunodeficiency virus type 1].Nihon Rinsho. 1992 Jun;50(6):1419-29. Nihon Rinsho. 1992. PMID: 1518160 Review. Japanese.
-
Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis.J Biol Regul Homeost Agents. 1996 Oct-Dec;10(4):83-91. J Biol Regul Homeost Agents. 1996. PMID: 9604776 Review.
Cited by
-
Metabolic Enzymes in Viral Infection and Host Innate Immunity.Viruses. 2023 Dec 24;16(1):35. doi: 10.3390/v16010035. Viruses. 2023. PMID: 38257735 Free PMC article. Review.
-
Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.J Virol. 2024 Feb 20;98(2):e0174223. doi: 10.1128/jvi.01742-23. Epub 2024 Jan 9. J Virol. 2024. PMID: 38193694 Free PMC article.
-
Small molecule inhibitors of mammalian glycosylation.Matrix Biol Plus. 2022 Mar 16;16:100108. doi: 10.1016/j.mbplus.2022.100108. eCollection 2022 Dec. Matrix Biol Plus. 2022. PMID: 36467541 Free PMC article.
-
Rational engineering of adeno-associated virus capsid enhances human hepatocyte tropism and reduces immunogenicity.Cell Prolif. 2022 Dec;55(12):e13339. doi: 10.1111/cpr.13339. Epub 2022 Sep 22. Cell Prolif. 2022. PMID: 36135100 Free PMC article.
-
Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2).ACS Omega. 2022 Jul 28;7(31):27038-27051. doi: 10.1021/acsomega.2c02345. eCollection 2022 Aug 9. ACS Omega. 2022. PMID: 35937682 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials